Laparoscopic adjustable gastric banding with liraglutide in adults with obesity and type 2 diabetes (GLIDE): a pilot randomised placebo controlled trial

INTRODUCTION: Obesity drives type 2 diabetes (T2DM) development. Laparoscopic adjustable gastric banding (LAGB) has lower weight reduction than other bariatric procedures. Liraglutide, a GLP-1 receptor agonist, improves weight and glycaemic control in patients with T2DM. This study aimed to determin...

Descripción completa

Detalles Bibliográficos
Autores principales: Coelho, Claudia, Dobbie, Laurence J., Crane, James, Douiri, Abdel, Learoyd, Annastazia E., Okolo, Olanike, Panagiotopoulos, Spyros, Pournaras, Dimitri J., Ramar, Sasindran, Rubino, Francesco, Singhal, Rishi, le Roux, Carel W., Taheri, Shahrad, McGowan, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599987/
https://www.ncbi.nlm.nih.gov/pubmed/37696925
http://dx.doi.org/10.1038/s41366-023-01368-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599987/
https://www.ncbi.nlm.nih.gov/pubmed/37696925
http://dx.doi.org/10.1038/s41366-023-01368-4

Ejemplares similares